National Health Investors (NYSE:NHI – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, November 5th. Analysts expect the company to announce earnings of $1.12 per share for the quarter. National Health Investors has set its FY24 guidance at $4.52-4.56 EPS and its FY 2024 guidance at 4.520-4.560 EPS.Parties interested in listening to the company’s conference call can do so using this link.
National Health Investors (NYSE:NHI – Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The firm had revenue of $84.97 million during the quarter, compared to analysts’ expectations of $64.95 million. During the same period in the prior year, the company posted $1.06 EPS. The company’s revenue for the quarter was up 9.1% compared to the same quarter last year. On average, analysts expect National Health Investors to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
National Health Investors Price Performance
Shares of NHI stock opened at $75.67 on Tuesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. The company has a market capitalization of $3.29 billion, a PE ratio of 25.74, a price-to-earnings-growth ratio of 4.72 and a beta of 1.04. The firm’s 50-day moving average is $80.58 and its two-hundred day moving average is $72.40. National Health Investors has a 12 month low of $48.97 and a 12 month high of $86.13.
National Health Investors Dividend Announcement
Analyst Ratings Changes
NHI has been the subject of several recent analyst reports. Truist Financial raised their target price on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Bank of America assumed coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price on the stock. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price target for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $73.29.
View Our Latest Research Report on NHI
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
- Five stocks we like better than National Health Investors
- What is Insider Trading? What You Can Learn from Insider Trading
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Using the MarketBeat Dividend Tax Calculator
- 3 Oil Stocks to Watch Before Earnings Come Out
- 3 Best Fintech Stocks for a Portfolio Boost
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.